In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

被引：32

作者：

Atanackovic, Djordje ^{[1
]}

Yousef, Sara ^{[1
,2
]}

Shorter, Christa ^{[1
]}

Tantravahi, Srinivas K. ^{[1
]}

Steinbach, Mary ^{[1
]}

Iglesias, Fiorella ^{[3
]}

Sborov, Douglas ^{[1
]}

Radhakrishnan, Sabarinath Venniyil ^{[1
]}

Chiron, Marielle ^{[4
]}

Miles, Rodney ^{[5
]}

Salama, Mohamed ^{[5
]}

Kroeger, Nicolaus ^{[2
]}

Luetkens, Tim ^{[1
]}

机构：

[1] Univ Utah, Huntsman Canc Inst, Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA

[2] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany

[3] Univ Utah, Pediat Oncol & Hematol, Salt Lake City, UT USA

[4] Sanofi, Paris, France

[5] Univ Utah, Dept Pathol, Salt Lake City, UT USA

来源：

LEUKEMIA | 2020年 / 34卷 / 01期

关键词：

SAR650984; ANTIGENS; NY-ESO-1; CELLS;

D O I：

10.1038/s41375-019-0536-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：317 / 321

页数：5

共 12 条

[1] Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation [J].

Atanackovic, Djordje ;

Arfsten, Julia ;

Cao, Yanran ;

Gnjatic, Sacha ;

Schnieders, Frank ;

Bartels, Katrin ;

Schilling, Georgia ;

Faltz, Christiane ;

Wolschke, Christine ;

Dierlamm, Judith ;

Ritter, Gerd ;

Eiermann, Thomas ;

Hossfeld, Dieter Kurt ;

Zander, Axel R. ;

Jungbluth, Achim A. ;

Old, Lloyd J. ;

Bokemeyer, Carsten ;

Kroeger, Nicolaus .

BLOOD, 2007, 109 (03) :1103-1112

[2] Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma [J].

Atanackovic, Djordje ;

Luetkens, Tim ;

Hildebrandt, York ;

Arfsten, Julia ;

Bartels, Katrin ;

Horn, Christiane ;

Stahl, Tanja ;

Cao, Yanran ;

Zander, Axel R. ;

Bokemeyer, Carsten ;

Kroeger, Nicolaus .

CLINICAL CANCER RESEARCH, 2009, 15 (04) :1343-1352

[3] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus [J].

Chen, Ji-Li ;

Dawoodji, Amina ;

Tarlton, Andrea ;

Gnjatic, Sacha ;

Tajar, Abdelouahid ;

Karydis, Ioannis ;

Browning, Judy ;

Pratap, Sarah ;

Verfaille, Christian ;

Venhaus, Ralph R. ;

Pan, Linda ;

Altman, Douglas G. ;

Cebon, Jonathan S. ;

Old, Lloyd L. ;

Nathan, Paul ;

Ottensmeier, Christian ;

Middleton, Mark ;

Cerundolo, Vincenzo .

INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) :E590-E601

[4] SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies [J].

Deckert, Jutta ;

Wetzel, Marie-Cecile ;

Bartle, Laura M. ;

Skaletskaya, Anna ;

Goldmacher, Victor S. ;

Vallee, Francois ;

Zhou-Liu, Qing ;

Ferrari, Paul ;

Pouzieux, Stephanie ;

Lahoute, Charlotte ;

Dumontet, Charles ;

Plesa, Adriana ;

Chiron, Marielle ;

Lejeune, Pascale ;

Chittenden, Thomas ;

Park, Peter U. ;

Blanc, Veronique .

CLINICAL CANCER RESEARCH, 2014, 20 (17) :4574-4583

[5] Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific kill T cells dentritic cells [J].

Dhodapkar, KM ;

Krasovsky, J ;

Williamson, B ;

Dhodapkar, MV .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :125-133

[6] SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide [J].

Jiang, H. ;

Acharya, C. ;

An, G. ;

Zhong, M. ;

Feng, X. ;

Wang, L. ;

Dasilva, N. ;

Song, Z. ;

Yang, G. ;

Adrian, F. ;

Qiu, L. ;

Richardson, P. ;

Munshi, N. C. ;

Tai, Y-T ;

Anderson, K. C. .

LEUKEMIA, 2016, 30 (02) :399-408

[7] SURFACE EXPRESSION OF HUMAN MYELOMA CELLS - AN ANALYSIS USING A PANEL OF MONOCLONAL-ANTIBODIES [J].

KATAGIRI, S ;

YONEZAWA, T ;

TAMAKI, T ;

KANAYAMA, Y ;

KUYAMA, J ;

OHNISHI, M ;

TSUBAKIO, T ;

KURATA, Y ;

TARUI, S .

ACTA HAEMATOLOGICA, 1984, 72 (06) :372-378

[8] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients [J].

Kumar, S. K. ;

Dispenzieri, A. ;

Lacy, M. Q. ;

Gertz, M. A. ;

Buadi, F. K. ;

Pandey, S. ;

Kapoor, P. ;

Dingli, D. ;

Hayman, S. R. ;

Leung, N. ;

Lust, J. ;

McCurdy, A. ;

Russell, S. J. ;

Zeldenrust, S. R. ;

Kyle, R. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2014, 28 (05) :1122-1128

[9] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma [J].

Lokhorst, H. M. ;

Plesner, T. ;

Laubach, J. P. ;

Nahi, H. ;

Gimsing, P. ;

Hansson, M. ;

Minnema, M. C. ;

Lassen, U. ;

Krejcik, J. ;

Palumbo, A. ;

van de Donk, N. W. C. J. ;

Ahmadi, T. ;

Khan, I. ;

Uhlar, C. M. ;

Wang, J. ;

Sasser, A. K. ;

Losic, N. ;

Lisby, S. ;

Basse, L. ;

Brun, N. ;

Richardson, P. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) :1207-1219

[10] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation [J].

Luetkens, Tim ;

Kobold, Sebastian ;

Cao, Yanran ;

Ristic, Marina ;

Schilling, Georgia ;

Tams, Sinje ;

Bartels, Britta Marlen ;

Templin, Julia ;

Bartels, Katrin ;

Hildebrandt, York ;

Yousef, Sara ;

Marx, Andreas ;

Haag, Friedrich ;

Bokemeyer, Carsten ;

Kroeger, Nicolaus ;

Atanackovic, Djordje .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (11) :1151-1162

← 1 2 →